Ondine Biomedical Inc.
LSE : OBP

June 29, 2011 11:56 ET

Ondine Biomedical Inc. ("Ondine Biomedical" or the "Company") Mail Out of Financial Statements and MD&A

FOR:  ONDINE BIOMEDICAL INC.

TSX, AIM SYMBOL:  OBP

June 29, 2011

Ondine Biomedical Inc. ("Ondine Biomedical" or the "Company") Mail Out of Financial Statements and MD&A

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 29, 2011) - Ondine Biomedical (TSX:OBP)(AIM:OBP) announces
that, in accordance with regulatory requirements, it has mailed out to its shareholders its Financial
Statements and Management Discussion and Analysis (MD&A) for the year ended December 31, 2010. Copies of these
documents are available during normal business hours on weekdays (except Saturdays, Sundays and public
holidays) free of charge from the Company's office at 888-1100 Melville Street, Vancouver, British Columbia,
Canada. In addition, these documents are available on the SEDAR website at www.sedar.com and on the Company's
website at www.ondinebio.com.


-30-

FOR FURTHER INFORMATION PLEASE CONTACT:

Ondine Biomedical Inc.
Carolyn Cross
Chairman and Chief Executive Officer
(604) 669-0555
ccross@ondinebio.com
www.ondinebio.com

OR

Canaccord Genuity Limited
Mark Williams
Nominated Adviser
+4420 7050 6500

-0-

Contact Information

  • Ondine Biomedical Inc.